Oncology and Hematology - Global Oncology Academy

Episodes 209-224 of 390

Updates on New Technologies and Imaging Agents in Healthcare
Updates on New Technologies and Imaging Agents in Healthcare
Project Oncology®
Updates on New Technologies and Imaging Agents in Healthcare
- Tyler J Bradshaw, PhD
The Impact of Advocacy on Healthcare
The Impact of Advocacy on Healthcare
Project Oncology®
The Impact of Advocacy on Healthcare
- Ashley L. Sumrall, MD
The Power of Patient Advocacy in Daily Clinical Practice
The Power of Patient Advocacy in Daily Clinical Practice
Project Oncology®
The Power of Patient Advocacy in Daily Clinical Practice
- Ashley L. Sumrall, MD
Targeting RET Alterations: Selpercatinib's Role in Pediatric Thyroid Cancer
Targeting RET Alterations: Selpercatinib's Role in Pediatric Thyroid Cancer
Project Oncology®
Targeting RET Alterations: Selpercatinib's Role in Pediatric Thyroid Cancer
Real-World Data on Treatment Choices for mccRCC
Real-World Data on Treatment Choices for mccRCC
Project Oncology®
Real-World Data on Treatment Choices for mccRCC
WHIM Syndrome Management: The First FDA Approval for Patients
WHIM Syndrome Management: The First FDA Approval for Patients
MinuteCE®
WHIM Syndrome Management: The First FDA Approval for Patients
1.00 program credit
- Teresa K. Tarrant, MD
1.00 program credit
MinuteCE®
WHIM Syndrome (A Chronic Neutropenic Disorder): Uncouple the Complex for HCPs and Patients
1.00 credit 7 episodes
- Jolan Walter, MD, PHD
- Teresa K. Tarrant, MD
- Peter E. Newburger, MD
- Jacob R. Bledsoe, MD
1.00 credit 7 episodes
WHIM Syndrome: A Misguided Immune System!
WHIM Syndrome: A Misguided Immune System!
MinuteCE®
WHIM Syndrome: A Misguided Immune System!
1.00 program credit
- Peter E. Newburger, MD
1.00 program credit
WHIM Syndrome and CXCR4 Variants: New Insights into Cellular Changes That Can Impact Patient Treatment Plans
WHIM Syndrome and CXCR4 Variants: New Insights into Cellular Changes That Can Impact Patient Treatment Plans
MinuteCE®
WHIM Syndrome and CXCR4 Variants: New Insights into Cellular Changes That Can Impact Patient Treatment Plans
1.00 program credit
- Jacob R. Bledsoe, MD
1.00 program credit
Goals of Therapy for WHIM Syndrome (a Chronic Neutropenic Disorder)
Goals of Therapy for WHIM Syndrome (a Chronic Neutropenic Disorder)
MinuteCE®
Goals of Therapy for WHIM Syndrome (a Chronic Neutropenic Disorder)
1.00 program credit
- Teresa K. Tarrant, MD
1.00 program credit
You Don’t Know WHIM Syndrome (A Chronic Neutropenic Disorder)
You Don’t Know WHIM Syndrome (A Chronic Neutropenic Disorder)
MinuteCE®
You Don’t Know WHIM Syndrome (A Chronic Neutropenic Disorder)
1.00 program credit
- Peter E. Newburger, MD
1.00 program credit
WHIM Syndrome: A Chronic Neutropenic Disorder
WHIM Syndrome: A Chronic Neutropenic Disorder
MinuteCE®
WHIM Syndrome: A Chronic Neutropenic Disorder
1.00 program credit
- Peter E. Newburger, MD
1.00 program credit
WHIM Syndrome Treatment: We Can Do Better!
WHIM Syndrome Treatment: We Can Do Better!
MinuteCE®
WHIM Syndrome Treatment: We Can Do Better!
1.00 program credit
- Jolan Walter, MD, PHD
1.00 program credit
Thyroid Cancer and Gender-Affirming Hormone Therapy: Exploring a Potential Link
Thyroid Cancer and Gender-Affirming Hormone Therapy: Exploring a Potential Link
Project Oncology®
Thyroid Cancer and Gender-Affirming Hormone Therapy: Exploring a Potential Link
Hepatocellular Carcinoma: Examining Its Prevalence and Prognostic Biomarkers
Hepatocellular Carcinoma: Examining Its Prevalence and Prognostic Biomarkers
Project Oncology®
Hepatocellular Carcinoma: Examining Its Prevalence and Prognostic Biomarkers
Nephrotoxicity in the Crosshairs: Optimizing Renal Cancer Care with Kidney Preservation
Nephrotoxicity in the Crosshairs: Optimizing Renal Cancer Care with Kidney Preservation
Project Oncology®
Nephrotoxicity in the Crosshairs: Optimizing Renal Cancer Care with Kidney Preservation

14/11